ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 1517

$341K Total Retail Price of All Prescriptions

Rank: 134 out of 1517

364 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Puerto Rico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $32 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 379 353 73 1 1
ENALAPRIL MALEATE 354 315 67 2 3
DONEPEZIL HCL 327 311 65 3 42
RANITIDINE HCL 297 268 68 4 4
QUETIAPINE FUMARATE 286 252 48 A 5 64
AMLODIPINE BESYLATE 263 225 47 6 7
CLONAZEPAM 261 221 65 B 7 22
LEVOTHYROXINE SODIUM 248 229 47 8 9
CLOPIDOGREL 243 227 54 9 21
FUROSEMIDE 219 214* 49 10 15
NAMENDA 219 202 43 10 63
OMEPRAZOLE 203 192 44 12 6
METFORMIN HCL 171 135 38 13 2
GABAPENTIN 152 141 36 14 5
PHENYTOIN SODIUM EXTENDED 145 109 26 15 119
GLIPIZIDE 144 144 34 16 14
SERTRALINE HCL 142 126 36 17 41
PENTOXIFYLLINE 126 112 24 18 43
SILVER SULFADIAZINE 124 119* 43 19 105
ZOLPIDEM TARTRATE 117 112* 26 20 25
LOSARTAN POTASSIUM 109 104* 27 21 8
TAMSULOSIN HCL 109 93 18 21 32
DIOVAN 93 88* 15 23 106
TRAMADOL HCL-ACETAMINOPHEN 90 85* 36 24 24
METOPROLOL TARTRATE 88 71 20 25 20
ISOSORBIDE DINITRATE 87 82* 15 26 93
GLIMEPIRIDE 85 80* 14 27 23
RISPERIDONE 82 63 22 A 28 82
FLUOXETINE HCL 81 70 21 29 72
DIGOX 80 75* 15 30 87
ATORVASTATIN CALCIUM 80 75* 20 30 18
TRAZODONE HCL 80 75* 16 30 111
FAMOTIDINE* 79 66 16 33 47
MEGESTROL ACETATE 79 74* 25 R 33 120
ATENOLOL 76 71* 14 35 12
DIVALPROEX SODIUM 74 44 19 36 132
PANTOPRAZOLE SODIUM 73 68* 14 37 39
PAROXETINE HCL 72 56 11 38 73
CITALOPRAM HBR 72 54 19 38 89
CARVEDILOL 71 66* 15 40 34
HYDROCHLOROTHIAZIDE 71 66* 13 40 13
BENZTROPINE MESYLATE 70 54 13 R 42 162
NABUMETONE 70 47 31 42 26
CAPTOPRIL 63 <11 <11 44 44
NYSTATIN 63 58* 25 44 255
EXELON 61 56* 12 46 223
LORAZEPAM 61 31 15 B 46 66
METOCLOPRAMIDE HCL 61 56* 22 46 118
LACTULOSE 59 54* 14 49 145
HALOPERIDOL 58 44 11 A 50 151
SPIRONOLACTONE 55 <11 <11 51 92
CLOTRIMAZOLE-BETAMETHASONE 54 49* 37 52 37
PRAVASTATIN SODIUM 54 <11 <11 52 27
TRAMADOL HCL 51 51 19 54 17
MUPIROCIN* 51 46* 32 54 134
OLANZAPINE 50 <11 <11 A 56 206
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.